Search results
Eli Lilly and Company (NYSE:LLY) Announces Earnings Results, Beats Expectations By $0.05 EPS
ETF DAILY NEWS· 4 days agoEli Lilly and Company (NYSE:LLY – Get Free Report) released its earnings results on Tuesday. The company reported $2.58 EPS for the quarter, topping the ...
Eli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoEli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript April 30, 2024 Eli Lilly and...
Eli Lilly and Company (NYSE:LLY) Price Target Raised to $1,001.00
ETF DAILY NEWS· 3 days agoEli Lilly and Company (NYSE:LLY – Free Report) had its price target hoisted by BMO Capital Markets from $900.00 to $1,001.00 in a report released on Wednesday ...
Eli Lilly and Company (NYSE:LLY) Price Target Raised to $900.00
ETF DAILY NEWS· 3 days agoEli Lilly and Company (NYSE:LLY – Free Report) had its price objective upped by JPMorgan Chase & Co. from $850.00 to $900.00 in a report published on Wednesday ...
Here's Why Eli Lilly Stock Remains a Screaming Buy
Motley Fool via Yahoo Finance· 5 days agoShares of Eli Lilly and Company (NYSE: LLY) have soared nearly 35% so far in 2024 and are only a few points away from doubling over the last 12 months.
Earnings call: Eli Lilly raises 2024 outlook on strong Q1 performance By Investing.com
Investing.com· 6 days agoEli Lilly and Company (NYSE:LLY) has reported a robust financial performance in the first quarter of 2024, with a significant increase in revenue and earnings ...
Eli Lilly and Company (NYSE:LLY) Shares Acquired by Cannell & Co.
ETF DAILY NEWS· 4 days agoCannell & Co. increased its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 65.9% in the 4th quarter, according to its most recent Form 13F filing ...
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
WMBD - FOX 43 Peoria· 7 days agoRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro,...
Despite 350% Rally, Novo Trades at Discount to Eli Lilly By Quiver Quantitative
Investing.com· 5 days agoAs the market dynamics shift, with both companies striving to capitalize on this high...
Lilly Raises 2024 Guidance as Zepbound Flies Off Shelves
Bloomberg· 7 days agoEli Lilly & Co.’s shares jumped after it raised its annual guidance on soaring demand for its...